Consistently, in NPM-ALK+ ALCL [13], as in EML4-ALK lung cancers [94] and ALK-mutated neuroblastoma [95,96], a synergistic activity of ALK and mTOR inhibition had been described, although the authors did not investigate the involvement of autophagy associated with cell death in these settings. This evidence concerns the gene EML4 and lung carcinoma.